This site is intended for Healthcare Professionals only.

UK to give third Covid jab to immunosuppressed


Share post:

Britain will give severely immunosuppressed people a third dose of Covid19 vaccine to increase their chances of generating a better immune response, although officials stressed the offer was separate from any broader booster vaccine programme.

Public Health England on Wednesday (Sep 1) said the decision to offer third doses to the immunosuppressed followed data that showed 40 per cent of immunosuppressed people generated only low levels of antibodies from two vaccine shots.

However, officials stressed the third dose was not a “booster” dose as it would be administered as part of the primary vaccination schedule and aimed at helping the initial process of generating an immune response.

“We want people with severely suppressed immune systems to have the best chance of gaining protection from Covid19 via vaccination,” said Wei Shen Lim, chair of Covid19 Immunisation for the Joint Committee on Vaccination and Immunisation (JCVI).

The JCVI’s final advice on the broader booster programme for the elderly and vulnerable is expected soon. The committee previously said it could start this month.

Third doses will be given to people with immunosuppressive conditions such as HIV/AIDS, and those who have received immunosuppressive treatments like chemotherapy. The move will impact less than 1 per cent of the population, around 400-500,000 people.

Officials said mRNA vaccines made by Pfizer and Moderna should be used as the third dose, as there was more data on these shots, but AstraZeneca’s vaccine could be added later if the data supported the move.

The government said it accepted the JCVI’s advice.

“The NHS will contact people as soon as possible to discuss their needs and arrange an appointment for a third dose where clinically appropriate,” health secretary Sajid Javid said.

“This is not the start of the booster programme – we are continuing to plan for this to begin in September.”


Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...